Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991.
about
Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary.Imaging findings in craniofacial childhood rhabdomyosarcoma.Primary ophthalmic rhabdomyosarcoma in 33 patients.Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma.Impairments that influence physical function among survivors of childhood cancerDelayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.Orbital rhabdomyosarcoma.Current chemotherapeutic strategies for rhabdomyosarcoma.Orbital rhabdomyosarcoma: multidisciplinary treatment experience.Surgical Principles for Children/Adolescents With Newly Diagnosed Rhabdomyosarcoma: A Report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.Orbital rhabdomyosarcomas: A review.Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study.Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology GroupChanges in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood cancer survivor study.Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patientsDental anomalies in children submitted to antineoplastic therapy.45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.Visual outcomes and late complications in paediatric orbital rhabdomyosarcoma.Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long-term follow-up study.Skull base reconstruction in the pediatric patientLong-term evaluation of orbital rhabdomyosarcoma in children.The prognosis and effects of local treatment strategies for orbital embryonal rhabdomyosarcoma: a population-based study.
P2860
Q33195404-07455A61-1882-4CC3-8D52-8463686F1CD0Q34176966-FF1FEFD0-1CDD-40B3-A0E1-10D6DD748500Q34331146-939205E6-3613-45A5-AEDC-6491BBA51E8EQ34484192-D4DDF7D2-333A-4133-8DE1-BEF383421A56Q35082766-1CAB3551-07C6-48DD-9DD9-46590E5C75E6Q35760674-6BF8B029-7CC8-4B35-99E4-6D83CA45CEF6Q35892026-F8372035-A5F5-4ACE-A35F-7EC603A1C36DQ36118405-88A1CD3C-1B96-4E6A-92FF-4E2919C13A0EQ36405636-565E7D9B-3C8A-4518-A3BA-B66681A0EFB6Q36674171-E4DC1D88-47C6-4671-B207-F19AA7EC83C8Q37163456-48FF0BE3-8FFB-4229-8FD7-2D4C34C13474Q37439333-580B905B-985B-4A17-B4B0-FD6044DA26F4Q37478437-A3285F87-CA31-4A54-8FB7-48FC8416EAADQ37552392-967C25E4-BC60-43C9-9A89-F40D9B072AEFQ37944088-07D7B090-8596-4EF1-9FD6-D107DEE8F3F0Q38223171-47902B9B-43D5-46A5-9179-AC8DD02D3A00Q38761564-C4172C74-55BA-43D4-936A-7238C67278F6Q38912753-96AEB416-2350-49AD-9282-9429C940A998Q41465765-47DA3301-00FA-4CE7-B89D-1BDAD54CA4AFQ42851850-7141921A-AA04-4C28-ACBC-51E0FFDFE8C9Q44779744-94AD69BD-263B-4DE9-BF4A-B922FA36411CQ55436255-6B74A5C0-7B6E-47B3-A668-D63BDF60462A
P2860
Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Late effects of therapy in 94 ...... ma Study (IRS)-III, 1984-1991.
@en
type
label
Late effects of therapy in 94 ...... ma Study (IRS)-III, 1984-1991.
@en
prefLabel
Late effects of therapy in 94 ...... ma Study (IRS)-III, 1984-1991.
@en
P2093
P2860
P1476
Late effects of therapy in 94 ...... ma Study (IRS)-III, 1984-1991.
@en
P2093
Anderson JR
Glicksman AS
Vassilopoulou-Sellin R
P2860
P304
P356
10.1002/(SICI)1096-911X(200006)34:6<413::AID-MPO6>3.0.CO;2-4
P577
2000-06-01T00:00:00Z